SCHEMBL29566809

SCHEMBL29566809

Cc1ccccc1-c1nc(NS(=O)(=O)c2cnn(C)c2)nc(Cl)c1Br

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 2/20 0.38
▸ HTR7 P34969 2/20 0.38
▸ KMT2A Q03164 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ PIK3CD O00329 1/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ PTPN11 Q06124 1/20 0.35
▸ MALT1 Q9UDY8 1/20 0.35
▸ CCNT1 O60563 3/20 0.34
▸ CCNB2 O95067 3/20 0.34
▸ CCNE2 O96020 3/20 0.34
▸ CDK1 P06493 3/20 0.34
▸ CCNB1 P14635 3/20 0.34
▸ CCNE1 P24864 3/20 0.34
▸ CDK2 P24941 3/20 0.34
▸ CDK9 P50750 3/20 0.34
▸ CDK5 Q00535 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310057 1.00 HTR1A (0.38) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24309379 0.90 HTR1A (0.39) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24309875 0.90 HTR1A (0.39) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24309824 0.88 BRAF (0.40) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24310066 0.87 HTR1A (0.38) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24309375 0.86 HTR1A (0.37) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24309383 0.86 HTR1A (0.39) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL29566455 0.86 HTR1A (0.37) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24309547 0.86 HTR1A (0.37) HTR1AHTR7KMT2ARXFP1TSHR
SCHEMBL24309587 0.85 HTR1A (0.36) HTR1AHTR7KMT2ARXFP1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback